Targeted Metabolomic Evaluation of Arginine Methylation and Cardiovascular Risks: Potential Mechanisms Beyond Nitric Oxide Synthase Inhibition
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Background— We examine the relationship of related posttranslational modification products of arginine methylation and coronary artery disease (CAD) phenotypes. Methods and Results— Plasma was isolated from 1011 consecutive consenting subjects undergoing elective diagnostic cardiac catheterization, and future major adverse cardiac events (MACE, including myocardial infarction, stroke, and death) at 3 years were investigated. Plasma levels of asymmetrical dimethylarginine (ADMA, endogenous nitric oxide synthase [NOS] inhibitor), symmetrical dimethylarginine (SDMA, which lacks NOS inhibitory activity), N-mono-methylarginine (MMA, a potent NOS inhibitor), methyl-lysine (Methyl-Lys, an unrelated methylated amino acid), arginine, and its major catabolites (citrulline and ornithine) were quantified simultaneously by stable isotope dilution HPLC with online electrospray ionization tandem mass spectrometry and adjusted for traditional risk factors, C-reactive protein, and estimated creatinine clearance. High SDMA levels (adjusted odds ratio [OR] 1.6, 95%CI, 1.1 to 2.6, P <0.001), low MMA (adjusted OR 0.5, 95%CI 0.4 to 0.8, P =0.007), but not ADMA (adjusted OR 1.3, 95%CI 0.88 to 2.0, P =0.177) were associated with increased prevalence of significantly obstructive CAD. Elevated levels of SDMA (adjusted Hazard Ratio [HR] 2.4, 95%CI 1.2 to 4.6, P =0.009), ADMA (adjusted HR 2.2, 95%CI 1.2 to 4.0, P =0.015), as well as an integrated index of arginine methylation [ArgMI=(ADMA+SDMA)/MMA] (adjusted HR 2.4, 95%CI 1.3 to 4.5, P =0.006) were significant independent predictors of incident MACE. ArgMI was predictive of incident MACE even following adjustments for global arginine bioavailability, particularly within secondary prevention patients. Conclusions— ADMA, SDMA, and the integrated quantification of arginine methylation (in the form of a methylation index) provided independent risk prediction for both significantly obstructive CAD and incident MACE in stable patients undergoing cardiac evaluation. These results suggest that factors beyond direct NOS inhibition contribute to the clinical associations between methylarginines and CAD outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Böger, R. H., Bode-Böger, S. M., Szuba, A., Tsao, P. S., Chan, J. R., Tangphao, O., Blaschke, T. F., & Cooke, J. P. (1998) · Circulation · doi:10.1161/01.cir.98.18.1842 · Cited by 1,181
Böger, R. H., Sullivan, L. M., Schwedhelm, E., Wang, T. J., Maas, R., Benjamin, E. J., Schulze, F., Xanthakis, V., Benndorf, R. A., & Vasan, R. S. (2009) · Circulation · doi:10.1161/circulationaha.108.838268 · Cited by 351
Vascular system: role of nitric oxide in cardiovascular diseases
Bian, K., Doursout, M., & Murad, F. (2008) · The Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2008.06632.x · Cited by 229 · cited 1×
“The significant associations between both prevalent significantly obstructive CAD and incident major adverse events and (1) elevations in plasma levels of SDMA (in the absence of a NOS inhibitory effect); (2) reductions in plasma levels of the potent NOS inhibitor MMA; and (3) increased levels of ArgMI, a ratio that s…”
Background
Cited by
The role of metabolites and metabolomics in clinically applicable biomarkers of disease
Mamas, M., Dunn, W. B., Neyses, L., & Goodacre, R. (2011) · Archives of Toxicology · doi:10.1007/s00204-010-0609-6 · Cited by 376
Shah, S. H., Kraus, W. E., & Newgard, C. B. (2012) · Circulation · doi:10.1161/circulationaha.111.060368 · Cited by 370
Wang, Z., Levison, B. S., Hazen, J. E., Donahue, L., Li, X.-M., & Hazen, S. L. (2014) · Analytical Biochemistry · doi:10.1016/j.ab.2014.03.016 · Cited by 320
Self-citationParadoxical association of enhanced cholesterol efflux with increased incident cardiovascular risks
Li, X.-M., Tang, W. H. W., Mosior, M. K., Huang, Y., Wu, Y., Matter, W., Gao, V., Schmitt, D., DiDonato, J. A., Fisher, E. A., et al. (2013) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.113.301373 · Cited by 301
Self-citationDevelopment, characterization and comparisons of targeted and non-targeted metabolomics methods
Ribbenstedt, A., Ziarrusta, H., & Benskin, J. P. (2018) · PLOS ONE · doi:10.1371/journal.pone.0207082 · Cited by 288
Metadata
- Authors
- Wang, Z., Tang, W. H. W., Cho, L., Brennan, D. M., & Hazen, S. L.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 2009-09
- Volume
- 29
- Issue
- 9
- Pages
- 1383-1391
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2118900351
- Cited by
- 123
- References
- 3
- FWCI
- 6.10
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.